Allergan plc (NYSE:AGN)

158.51
Delayed Data
As of 4:00pm ET
 -0.08 / -0.05%
Today’s Change
142.81
Today|||52-Week Range
256.80
-3.10%
Year-to-Date

Today’s Trading

Previous close158.59
Today’s open159.19
Day’s range157.28 - 161.15
Volume3,180,410
Average volume (3 months)3,159,742
Market cap$52.0B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-134.55%
Earnings growth (this year)-4.33%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+9.40%
P/E ratioNM
Price/Sales3.43
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.06-0.17%
ABTAbbott Laboratories-0.69-1.15%
LLYEli Lilly and Co-0.69-0.87%
NVONovo Nordisk-0.43-0.90%
Data as of 4:03pm ET, 04/20/2018

Financials

Next reporting dateApril 30, 2018
EPS forecast (this quarter)$3.71
Annual revenue (last year)$15.9B
Annual profit (last year)-$4.1B
Net profit margin-23.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Executive Vice President-
Global Operations
Wayne R. Swanton
Corporate headquarters
Dublin, Dublin

Forecasts